Year |
Citation |
Score |
2021 |
Jacobs B, Palmer N, Shetty T, Dimaras H, Hajrasouliha A, Jusufbegovic D, Corson TW. Patient preferences in retinal drug delivery. Scientific Reports. 11: 18996. PMID 34556761 DOI: 10.1038/s41598-021-98568-7 |
0.635 |
|
2021 |
Shetty T, Park B, Corson TW. Measurement of mitochondrial respiration in the murine retina using a Seahorse extracellular flux analyzer. Star Protocols. 2: 100533. PMID 34027490 DOI: 10.1016/j.xpro.2021.100533 |
0.57 |
|
2021 |
Sardar Pasha SPB, Shetty T, Lambert-Cheatham NA, Sishtla K, Mathew D, Muniyandi A, Patwari N, Bhatwadekar AD, Corson TW. Retinal Phenotyping of Ferrochelatase Mutant Mice Reveals Protoporphyrin Accumulation and Reduced Neovascular Response. Investigative Ophthalmology & Visual Science. 62: 36. PMID 33620374 DOI: 10.1167/iovs.62.2.36 |
0.623 |
|
2021 |
Shetty T, Park B, Corson TW. Measurement of mitochondrial respiration in the murine retina using a Seahorse extracellular flux analyzer Star Protocols. 2: 100533. DOI: 10.1016/j.xpro.2021.100533 |
0.55 |
|
2020 |
Doud EH, Shetty T, Abt M, Mosley AL, Corson TW, Mehta A, Yeh ES. NF-κB Signaling Is Regulated by Fucosylation in Metastatic Breast Cancer Cells. Biomedicines. 8. PMID 33322811 DOI: 10.3390/biomedicines8120600 |
0.549 |
|
2020 |
Shetty T, Corson TW. Mitochondrial Heme Synthesis Enzymes as Therapeutic Targets in Vascular Diseases. Frontiers in Pharmacology. 11: 1015. PMID 32760270 DOI: 10.3389/Fphar.2020.01015 |
0.655 |
|
2020 |
Shetty T, Sishtla K, Park B, Repass MJ, Corson TW. Heme Synthesis Inhibition Blocks Angiogenesis via Mitochondrial Dysfunction. Iscience. 23: 101391. PMID 32755804 DOI: 10.1016/J.Isci.2020.101391 |
0.69 |
|
2019 |
Schwikkard S, Whitmore H, Sishtla K, Sulaiman RS, Shetty T, Basavarajappa HD, Waller C, Alqahtani A, Frankemoelle L, Chapman A, Crouch N, Wetschnig W, Knirsch W, Andriantiana J, Mas-Claret E, et al. The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae ( sensu APGII). Journal of Natural Products. PMID 30951308 DOI: 10.1021/Acs.Jnatprod.8B00989 |
0.554 |
|
2018 |
Sardar Pasha SPB, Sishtla K, Sulaiman RS, Park B, Shetty T, Shah F, Fishel ML, Wikel JH, Kelley MR, Corson TW. Ref-1/APE1 inhibition with novel small molecules blocks ocular neovascularization. The Journal of Pharmacology and Experimental Therapeutics. PMID 30076264 DOI: 10.1124/Jpet.118.248088 |
0.743 |
|
2017 |
Basavarajappa HD, Sulaiman RS, Qi X, Shetty T, Sheik Pran Babu S, Sishtla KL, Lee B, Quigley J, Alkhairy S, Briggs CM, Gupta K, Tang B, Shadmand M, Grant MB, Boulton ME, et al. Ferrochelatase is a therapeutic target for ocular neovascularization. Embo Molecular Medicine. PMID 28377496 DOI: 10.15252/Emmm.201606561 |
0.662 |
|
Show low-probability matches. |